Hydroxy metabolites of the Alzheimer's drug candidate 3-[(2, 4-dimethoxy) benzylidene]-anabaseine dihydrochloride (GTS-21): their molecular properties, interactions with brain … WR Kem, VM Mahnir, L Prokai, RL Papke, X Cao, S LeFrancois, ... Molecular pharmacology 65 (1), 56-67, 2004 | 117 | 2004 |
The nemertine toxin anabaseine and its derivative DMXBA (GTS-21): Chemical and pharmacological properties W Kem, F Soti, K Wildeboer, S LeFrancois, K MacDougall, DQ Wei, ... Marine Drugs 4 (3), 255-273, 2006 | 85 | 2006 |
Nicotinic Receptor Inhibition by Tetraponera Ant Alkaloids WR Kem, K Wildeboer, S LeFrancois, M Raja, W Marszalec, JC Braekman Cellular and molecular neurobiology 24, 535-551, 2004 | 24 | 2004 |
A computational study of the binding of 3-(arylidene) anabaseines to two major brain nicotinic acetylcholine receptors and to the acetylcholine binding protein SH Slavov, M Radzvilovits, S LeFrancois, IB Stoyanova-Slavova, F Soti, ... European journal of medicinal chemistry 45 (6), 2433-2446, 2010 | 10 | 2010 |
Hydroxy metabolites of the Alzheimer’s drug candidate DMXBA (GTS-21): Their interactions with brain nicotinic receptors, and brain penetration WR Kem, VM Mahnir, L Prokai, RM Papke, XF Cao, S LeFrancois, ... Mol. Pharmacol 65, 56-67, 2004 | 8 | 2004 |
A structure activity investigation of benzylidene anabaseine interactions with the alpha7 nicotinic acetylcholine receptor. SE Lefrancois | 3 | 2004 |